These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27317186)

  • 1. Incorporation of Heterologous Proteins in Engineered Exosomes.
    Manfredi F; Di Bonito P; Arenaccio C; Anticoli S; Federico M
    Methods Mol Biol; 2016; 1448():249-60. PubMed ID: 27317186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.
    Lattanzi L; Federico M
    Vaccine; 2012 Nov; 30(50):7229-37. PubMed ID: 23099330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.
    Di Bonito P; Chiozzini C; Arenaccio C; Anticoli S; Manfredi F; Olivetta E; Ferrantelli F; Falcone E; Ruggieri A; Federico M
    Int J Nanomedicine; 2017; 12():4579-4591. PubMed ID: 28694699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.
    Ferrantelli F; Arenaccio C; Manfredi F; Olivetta E; Chiozzini C; Leone P; Percario Z; Ascione A; Flego M; Di Bonito P; Accardi L; Federico M
    Int J Nanomedicine; 2019; 14():8755-8768. PubMed ID: 31806970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors.
    Ferrantelli F; Manfredi F; Chiozzini C; Anticoli S; Olivetta E; Arenaccio C; Federico M
    Mol Biotechnol; 2018 Nov; 60(11):773-782. PubMed ID: 30167966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens.
    Anticoli S; Manfredi F; Chiozzini C; Arenaccio C; Olivetta E; Ferrantelli F; Capocefalo A; Falcone E; Ruggieri A; Federico M
    Biotechnol J; 2018 Apr; 13(4):e1700443. PubMed ID: 29274250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.
    Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M
    Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.
    Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP
    J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1.
    Arenaccio C; Anticoli S; Manfredi F; Chiozzini C; Olivetta E; Federico M
    Retrovirology; 2015 Oct; 12():87. PubMed ID: 26502902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
    Di Bonito P; Grasso F; Mochi S; Petrone L; Fanales-Belasio E; Mei A; Cesolini A; Laconi G; Conrad H; Bernhard H; Dembek CJ; Cosma A; Santini SM; Lapenta C; Donati S; Muratori C; Giorgi C; Federico M
    Virology; 2009 Dec; 395(1):45-55. PubMed ID: 19800648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune response.
    Di Bonito P; Ridolfi B; Columba-Cabezas S; Giovannelli A; Chiozzini C; Manfredi F; Anticoli S; Arenaccio C; Federico M
    Viruses; 2015 Mar; 7(3):1079-99. PubMed ID: 25760140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nef is secreted in exosomes from Nef.GFP-expressing and HIV-1-infected human astrocytes.
    Pužar Dominkuš P; Ferdin J; Plemenitaš A; Peterlin BM; Lenassi M
    J Neurovirol; 2017 Oct; 23(5):713-724. PubMed ID: 28762184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes.
    Columba Cabezas S; Federico M
    Cell Microbiol; 2013 Mar; 15(3):412-29. PubMed ID: 23072732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-Terminal Domain of Nef
    Chiozzini C; Manfredi F; Ferrantelli F; Leone P; Giovannelli A; Olivetta E; Federico M
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33921215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal Fatty Acids of NEF
    Chiozzini C; Manfredi F; Arenaccio C; Ferrantelli F; Leone P; Federico M
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32456079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes in HIV infection: A review and critical look.
    Ellwanger JH; Veit TD; Chies JAB
    Infect Genet Evol; 2017 Sep; 53():146-154. PubMed ID: 28546080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering exosomes for targeted drug delivery.
    Liang Y; Duan L; Lu J; Xia J
    Theranostics; 2021; 11(7):3183-3195. PubMed ID: 33537081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells.
    Marusic C; Nuttall J; Buriani G; Lico C; Lombardi R; Baschieri S; Benvenuto E; Frigerio L
    BMC Biotechnol; 2007 Feb; 7():12. PubMed ID: 17324250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nef neutralizes the ability of exosomes from CD4+ T cells to act as decoys during HIV-1 infection.
    de Carvalho JV; de Castro RO; da Silva EZ; Silveira PP; da Silva-Januário ME; Arruda E; Jamur MC; Oliver C; Aguiar RS; daSilva LL
    PLoS One; 2014; 9(11):e113691. PubMed ID: 25423108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.